Dear St Anne’s Student, I hope you have been able to enjoy the spring vacation, and that you are well and looking forward to the term ahead. This message is intended specifically for all of you who do not have a confirmed date to be back in Oxford but are waiting to hear if you …
We are proud to announce that the NHS is set to trial a “personalised medicine” DNA test developed by Genomics, a biotech company founded and run by St Anne’s Honorary Fellow, Professor Sir Peter Donnelly. The goal is to use the test to identify those whose genes make them more vulnerable to strokes and heart …
The 2021 Recognition of Distinction Exercise is now open for applications. All those employed by the University in academic or senior research roles are eligible to apply, as are other University employees who are making a significant and sustained academic contribution to the University. Individuals not employed by the University, but who are employed on …
We are delighted to announce that Professor Cecilia Lindgren, St Anne’s Senior Research Fellow in Medical Sciences, has been appointed as the new Director of the University of Oxford’s Big Data Institute. The availability of biomedical information, also known as ‘big data’, is increasing rapidly. The analysis of this data provides an opportunity for transforming the …
Lionheart Ventures is a venture capital firm focused on reducing existential risk. Their mission is to ensure humanity’s security for a thriving future. Founded by St Anne’s alum David Langer (Mathematics, 2007), Lionheart’s main areas of investment focus are transformative artificial intelligence and frontier mental health technologies. Summer 2024 Analyst Internship Each summer …